RNA-Seq Blog Transcriptome Research & Industry News
The time is right to give therapeutic mRNA a special forum.
mRNA – the molecule whose medical use seemed almost out of reach until a few years ago – is now in substantial progress to become a new class of drugs. mRNA may transform the treatment of many human diseases and disorders.
The 2nd International mRNA Health Conference, which will be held on November 11 and 12, 2014, in Cambridge, Massachusetts, will bring together more than 150 attendees from leading international pharmaceutical and biotechnology companies and academic institutions. During the two-day event, colleagues from around the world will share the vanguard of research and technologies poised to unlock the tremendous medical potential of mRNA for many therapeutic indications.
Conference Program
Tuesday, November 11th
| 8:00 am | Opening registration and reception |
| 9:00 am | Welcome remarks by the Organizing Committee |
Introductory Sessions
| 9:30 am | Jack Szostak, Massachusetts General Hospital, 2009 Nobel Prize in Physiology or Medicine mRNA and the origin of life |
| 10:00 am | John Reynders, Moderna Therapeutics Is mRNA like software? |
| 10:30 am | Phil Sharp, MIT Institute, 1993 Nobel Prize in Physiology or Medicine Non-coding RNA in the synthesis and regulation of mRNA |
| 11:00 am | Coffee Break |
| 11:30 am | Ingmar Hoerr, CureVac Optimizing mRNA for versatile medical approaches |
| 12:00 pm | Ugur Sahin, BioNTech mRNA for Individualized Cancer Immunotherapy |
| 12:30 pm | Lunch Break |
| 1:30 pm | Session Vaccines |
| 1:30 pm | Chair introduction by Ugur Sahin, BioNTech |
| 1:35 pm | Andrew Geall, Novartis |
| 2:05 pm | Steve Pascolo, University Hospital of Zurich |
| 2:35 pm | Ulrike Gnad-Vogt, CureVac |
| 3:05 pm | Kris Thielemans, University of Brussels |
| 3:35 pm | Coffee Break |
| 3:55 pm | Session Therapeutics |
| 3:55 pm | Chair introduction by Rahul Kakkar, AstraZeneca |
| 4:00 pm | Regina Fritsche-Danielson, AstraZeneca |
| 4:30 pm | Ken Chien, Karolinska University |
| 5:00 pm | Carsten Rudolph, Ethris |
| 5:30 pm | Igor Splawski, Novartis Institutes for BioMedical Research |
| 6:00 pm | Session End |
Networking Evening State Room Boston
| 6:15 pm | Bus to Reception Dinner |
| 7:00 pm | Reception Dinner with Scientific Poster Session |
Wednesday, November 12, 2014
| 8:00 am | Breakfast |
| 9:00 am | Panel Discussion Vaccines |
| Chaired by: Ugur Sahin, BioNTech Panelists: Andrew Geall, Novartis Steve Pascolo, University Hospital of Zurich Ulrike Gnad-Vogt, CureVac Kris Thielemans, University of Brussels |
|
| 10:00 am | Coffee Break |
| 10:30 am | Panel Discussion Therapeutics |
| Chaired by: Stephane Bancel, Moderna Therapeutics Panelists: Regina Fritsche-Danielson, AstraZeneca Ken Chien, Karolinska University Carsten Rudolph, Ethris Igor Splawski, Novartis Institutes for BioMedical Research |
|
| 11:30 am | Panel Discussion mRNA Products & Manufacturing |
| Chaired by: Ingmar Hoerr, CureVac Panelists: Steve Harbin, Moderna Therapeutics Peter Hutt, Former FDA General Counsel Andreas Kuhn, BioNTech Anton McCaffrey, TriLink Florian von der Mülbe, CureVac |
|
| 12:30 pm | Lunch Break |
| 1:30 pm | Peter Hutt, Former FDA General Counsel FDA Regulation of mRNA Biological Drugs |
| 2:00 pm | Dan Wattendorf, DARPA Impact of mRNA on Global Health |
| 2:30 pm | Closing remarks by the Organizing Committee |
| 3:00 pm | End of conference |
Download 2nd International mRNA Health Conference 2014 Program
download PDF
